SGLT2Is are also thought to enhance insulin sensitivity and diminish chronic inflammation, which may help mitigate the inflammatory microenvironment in T2DM that facilitates cancer development [10–12]. This evidence concerns the gene INS and type 2 diabetes mellitus.